Literature DB >> 10595913

Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture.

T Knittel1, D Kobold, J Dudas, B Saile, G Ramadori.   

Abstract

During liver tissue repair, hepatic stellate cells (HSCs), a pericyte-like nonparenchymal liver cell population, transform from a quiescent status (resting HSCs) into myofibroblast like cells (activated HSCs); the latter is the principal matrix-synthesizing cell of the liver. Although several factors have been shown to be involved in this important process, the molecular mechanisms regulating HSC activation are still under investigation. To identify key regulatory proteins involved in the HSC activation process, we used different mRNA display technologies, with cDNAs prepared from HSCs at different stages of in vitro activation. With the latter technique, the transcription factor Ets-1 was detected through its down-regulation during activation. As confirmed by Northern blot and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, mRNAs coding for Ets-1 were present in the highest amounts in freshly isolated HSCs and in HSCs 2 days after plating (classified as resting HSCs/early activated HSCs) and were diminished in HSCs 7 days after plating (activated cells). Ets-1 protein was present in HSC-lysates, as assessed by Western blot, and bound to an oligonucleotide containing the Ets-1 consensus cis-acting motif, as demonstrated by electrophoretic mobility shift assay. Ets-1 binding activity peaked in nuclear extracts prepared from resting/early activated cells and was diminished in extracts derived from fully activated cells. In contrast, binding activity of the transcription factors TFIID, AP-1, and SP-1 was highest in activated HSCs and only barely detectable in resting/early activated HSCs. By Northern blot and RT-PCR analysis, Ets-1-specific transcripts were present in parenchymal and other nonparenchymal liver cells too, illustrating that hepatic Ets-1 expression is not specific or restricted to HSCs. However, the unique pattern of Ets-1 binding activity present in resting versus activated HSCs and its known implications for cellular differentiation and tissue remodeling suggest that Ets-1 could be of crucial importance for HSC activation and hepatic tissue repair.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595913      PMCID: PMC1866949          DOI: 10.1016/S0002-9440(10)65502-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Glial fibrillary acidic protein--a cell type specific marker for Ito cells in vivo and in vitro.

Authors:  K Neubauer; T Knittel; S Aurisch; P Fellmer; G Ramadori
Journal:  J Hepatol       Date:  1996-06       Impact factor: 25.083

Review 2.  Signal transduction in hepatic stellate cells.

Authors:  M Pinzani; F Marra; V Carloni
Journal:  Liver       Date:  1998-02

3.  Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta.

Authors:  S Jovinge; A Hultgårdh-Nilsson; J Regnström; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-03       Impact factor: 8.311

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.

Authors:  P Coffer; M de Jonge; A Mettouchi; B Binetruy; J Ghysdael; W Kruijer
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

6.  Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells.

Authors:  J E Poulos; J D Weber; J M Bellezzo; A M Di Bisceglie; R S Britton; B R Bacon; J J Baldassare
Journal:  Am J Physiol       Date:  1997-10

7.  The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts.

Authors:  F Gilles; M B Raes; D Stéhelin; B Vandenbunder; V Fafeur
Journal:  Exp Cell Res       Date:  1996-02-01       Impact factor: 3.905

8.  The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites.

Authors:  A Gutman; B Wasylyk
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

9.  The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.

Authors:  C Wasylyk; A Gutman; R Nicholson; B Wasylyk
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

10.  Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain.

Authors:  A R Kornblihtt; K Vibe-Pedersen; F E Baralle
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

View more
  12 in total

Review 1.  Transcriptional regulation of hepatic stellate cell activation.

Authors:  D A Mann; D E Smart
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Collagen binding alpha2beta1 and alpha1beta1 integrins play contrasting roles in regulation of Ets-1 expression in human liver myofibroblasts.

Authors:  Iya Znoyko; Maria Trojanowska; Adrian Reuben
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 3.  Ets transcription factors in intestinal morphogenesis, homeostasis and disease.

Authors:  Paul Jedlicka; Arthur Gutierrez-Hartmann
Journal:  Histol Histopathol       Date:  2008-11       Impact factor: 2.303

4.  Heterogeneity of HSCs in a Mouse Model of NASH.

Authors:  Sara Brin Rosenthal; Xiao Liu; Souradipta Ganguly; Debanjan Dhar; Martina P Pasillas; Eugenia Ricciardelli; Rick Z Li; Ty D Troutman; Tatiana Kisseleva; Christopher K Glass; David A Brenner
Journal:  Hepatology       Date:  2021-08-10       Impact factor: 17.425

5.  Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.

Authors:  Xiao Liu; Jun Xu; Sara Rosenthal; Ling-Juan Zhang; Ryan McCubbin; Nairika Meshgin; Linshan Shang; Yukinori Koyama; Hsiao-Yen Ma; Sonia Sharma; Sven Heinz; Chris K Glass; Chris Benner; David A Brenner; Tatiana Kisseleva
Journal:  Gastroenterology       Date:  2020-01-23       Impact factor: 33.883

6.  Signal Transduction and Molecular Regulation in Fatty Liver Disease.

Authors:  Xiaocheng Charlie Dong; Kushan Chowdhury; Menghao Huang; Hyeong Geug Kim
Journal:  Antioxid Redox Signal       Date:  2021-06-03       Impact factor: 7.468

7.  Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

Authors:  Fuqu Yu; Josephine N Harada; Helen J Brown; Hongyu Deng; Moon Jung Song; Ting-Ting Wu; Juran Kato-Stankiewicz; Christian G Nelson; Jeffrey Vieira; Fuyuhiko Tamanoi; Sumit K Chanda; Ren Sun
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

Review 8.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

9.  The induction of CCN2 by TGFbeta1 involves Ets-1.

Authors:  Jonathan P Van Beek; Laura Kennedy; Jason S Rockel; Suzanne M Bernier; Andrew Leask
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

10.  Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells.

Authors:  Takeya Sato; Mitsuru Sato; Mitsutaka Miura; Nobuyo Higashi; Da-Ren Wang; Shinsuke Suzuki; Katsuyuki Imai; Naosuke Kojima; Haruki Senoo
Journal:  Comp Hepatol       Date:  2004-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.